Inventor
GOLDBERG DANIEL R
US45 patents
⚠️ This page may combine multiple inventors who share the name “GOLDBERG DANIEL R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM PHARMA
15 patentsUS6689804B2Feb 10, 2004
Small molecules useful in the treatment of inflammatory disease
BOEHRINGER INGELHEIM PHARMA46 citations94
US6852717B2Feb 8, 2005
Compounds useful as anti-inflammatory agents
BOEHRINGER INGELHEIM PHARMA43 citations92
US6489328B2Dec 3, 2002
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA29 citations92
US6492408B1Dec 10, 2002
Small molecules useful in the treatment of inflammatory disease
BOEHRINGER INGELHEIM PHARMA35 citations91
US7511042B2Mar 31, 2009
Triazole compounds
BOEHRINGER INGELHEIM PHARMA16 citations82
US7078419B2Jul 18, 2006
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA15 citations82
US6765009B2Jul 20, 2004
1,4-Disubstituted benzo-fused compounds
BOEHRINGER INGELHEIM PHARMA21 citations79
US6844435B2Jan 18, 2005
Heterocyclic compounds useful as inhibitors of tyrosine kinases
BOEHRINGER INGELHEIM PHARMA4 citations62
US7790712B2Sep 7, 2010
Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA5 citations61
US7335657B2Feb 26, 2008
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA2 citations61
US7592332B2Sep 22, 2009
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA4 citations60
US7550494B2Jun 23, 2009
Small molecules useful in the treatment of inflammatory disease
BOEHRINGER INGELHEIM PHARMA5 citations59
US7285545B2Oct 23, 2007
Cytokine inhibitors
BOEHRINGER INGELHEIM PHARMA1 citations49
US7115644B2Oct 3, 2006
Heterocyclic compounds
BOEHRINGER INGELHEIM PHARMA1 citations47
US7550461B2Jun 23, 2009
Benzofuran and benzothiophene compounds useful in treating cytokine mediated diseases
BOEHRINGER INGELHEIM PHARMA0 citations40
SMITH & NEPHEW INC
9 patentsUS9345576B2May 24, 2016
Orthopedic augments having recessed pockets
SMITH & NEPHEW INC12 citations92
US9848989B2Dec 26, 2017
Orthopedic augments having recessed pockets
SMITH & NEPHEW INC6 citations83
US9707097B2Jul 18, 2017
Orthopedic implant augments
SMITH & NEPHEW INC4 citations83
US10265178B2Apr 23, 2019
Orthopedic augments having recessed pockets
SMITH & NEPHEW INC2 citations72
US9814582B2Nov 14, 2017
Orthopedic augments having recessed pockets
SMITH & NEPHEW INC3 citations72
US12232978B2Feb 25, 2025
Orthopedic implant augments
SMITH & NEPHEW INC0 citations62
US11344432B2May 31, 2022
Orthopedic implant augments
SMITH & NEPHEW INC0 citations62
US11135067B2Oct 5, 2021
Orthopedic augments having recessed pockets
SMITH & NEPHEW INC0 citations62
US10383744B2Aug 20, 2019
Orthopedic implant augments
SMITH & NEPHEW INC0 citations51
GYRUS ACMI INC
8 patentsUS10028644B2Jul 24, 2018
Oblong endoscope sheath
GYRUS ACMI INC11 citations92
US10022040B2Jul 17, 2018
Endoscope system including a resilient reservoir
GYRUS ACMI INC8 citations91
US9332894B2May 10, 2016
Endoscope system including a resilient reservoir
GYRUS ACMI INC9 citations91
US10478052B2Nov 19, 2019
Oblong endoscope sheath
GYRUS ACMI INC5 citations84
US11266303B2Mar 8, 2022
Oblong endoscope sheath
GYRUS ACMI INC2 citations73
US10799097B2Oct 13, 2020
Endoscope system including a resilient reservoir
GYRUS ACMI INC2 citations71
US12262870B2Apr 1, 2025
Oblong endoscope sheath
GYRUS ACMI INC0 citations62
US12533152B2Jan 27, 2026
Methods of reciprocation in a surgical shaver
GYRUS ACMI INC0 citations57
ROIVANT SCIENCES GMBH
5 patentsUS10045988B2Aug 14, 2018
Spirocyclic compounds as tryptophan hydroxylase inhibitors
ROIVANT SCIENCES GMBH11 citations91
US10946018B2Mar 16, 2021
Spirocyclic compounds as tryptophan hydroxylase inhibitors
ROIVANT SCIENCES GMBH6 citations82
US10660893B2May 26, 2020
Spirocyclic compounds as tryptophan hydroxylase inhibitors
ROIVANT SCIENCES GMBH6 citations82
US10350208B2Jul 16, 2019
Spirocyclic compounds as tryptophan hydroxylase inhibitors
ROIVANT SCIENCES GMBH7 citations82
US10710948B2Jul 14, 2020
Processes for preparing (R)-1-(5-chloro-[1,1″-biphenyl] -2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1″-biphenyl]-2-yl)-2,2,2-trifluoroethanone
ROIVANT SCIENCES GMBH0 citations51
KAROS PHARMACEUTICALS INC
4 patentsUS9199994B2Dec 1, 2015
Spirocyclic compounds as tryptophan hydroxylase inhibitors
KAROS PHARMACEUTICALS INC31 citations96
US9750740B2Sep 5, 2017
Spirocyclic compounds as tryptophan hydroxylase inhibitors
KAROS PHARMACEUTICALS INC14 citations91
US9512122B2Dec 6, 2016
Spirocyclic compounds as tryptophan hydroxylase inhibitors
KAROS PHARMACEUTICALS INC15 citations91
US9611201B2Apr 4, 2017
Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
KAROS PHARMACEUTICALS INC0 citations51